Correlation Between Aerovate Therapeutics and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Enliven Therapeutics, you can compare the effects of market volatilities on Aerovate Therapeutics and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Enliven Therapeutics.
Diversification Opportunities for Aerovate Therapeutics and Enliven Therapeutics
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Aerovate and Enliven is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Enliven Therapeutics
Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 1.65 times more return on investment than Enliven Therapeutics. However, Aerovate Therapeutics is 1.65 times more volatile than Enliven Therapeutics. It trades about 0.24 of its potential returns per unit of risk. Enliven Therapeutics is currently generating about -0.23 per unit of risk. If you would invest 218.00 in Aerovate Therapeutics on August 28, 2024 and sell it today you would earn a total of 50.00 from holding Aerovate Therapeutics or generate 22.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aerovate Therapeutics vs. Enliven Therapeutics
Performance |
| Timeline |
| Aerovate Therapeutics |
| Enliven Therapeutics |
Aerovate Therapeutics and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aerovate Therapeutics and Enliven Therapeutics
The main advantage of trading using opposite Aerovate Therapeutics and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. HCW Biologics | Aerovate Therapeutics vs. Scpharmaceuticals | Aerovate Therapeutics vs. Milestone Pharmaceuticals |
| Enliven Therapeutics vs. Capricor Therapeutics | Enliven Therapeutics vs. Soleno Therapeutics | Enliven Therapeutics vs. Bio Path Holdings | Enliven Therapeutics vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |